INTRODUCTION Cardiac surgery has specific characteristics that make blood pressure management different. These are patients with heart disease, sometimes very severe, in which any stimulus is likely to cause significant hemodynamic instability. https://www.selleckchem.com/products/sbe-b-cd.html In addition, the need for the use of extracorporeal circulation defines different scenarios where neither hypotension nor hypertension can be treated in the same way. DEVELOPMENT The causes of hemodynamic instability are different in cardiac surgery due to its peculiarities. Optimization of heart rate, volemia, peripheral vascular resistances, management during extracorporeal circulation and early identification of conditions such as vasoplegic syndrome are key in maintaining blood pressure within the limits of normality. CONCLUSIONS Management within the limits of normal blood pressure in the case of cardiac surgery is an important prognostic factor and the specific characteristics of the different scenarios are important to be known. The choice of the type of blood pressure monitoring in patients with uncontrolled hypertension varies depending on the patient's risk due to his previous pathology and cardiovascular risk, as well as the risk of the type of surgical intervention. We must assess the possibility of using new non-invasive monitors that allow optimal control of blood pressure continuously and evaluate the usefulness of new hemodynamic índices that are still under study. Postoperative hypertension (HT) is defined as a significant rise in blood pressure (BP) during the immediate postoperative period that can lead to serious neurological, cardiovascular or surgical complications requiring urgent management. In non-cardiac surgery, HT is common and leads to an increase in adverse events, including stroke, injury and myocardial infarction, and bleeding. In certain procedures, such as carotid endarterectomy, aortic aneurysm surgery or intracranial surgery, postoperative HT has specific considerations not present in other surgeries and may be associated with worse neurological outcomes. Among the risk factors for its occurrence is the history of hypertension prior to surgery, although not all episodes of postoperative hypertension correspond to chronic hypertensive patients. In the first hours after surgery, pain, agitation, hypoxemia or bladder distension, among other factors, may contribute to the appearance of hypertension. Although there is no clear consensus on the thresholds and goals of antihypertensive therapy, it is usually initiated when the systolic BP is &gt;180mmHg or the diastolic BP is &gt;110mmHg, especially if it persists after treating possible underlying causes. The use of oral medication in the postoperative period may be limited by the circumstances of the surgery, but also by the slow onset of action of the drugs and the difficulty of controlling the degree of pressure drop. If oral administration of medication is not feasible, we recommend the use of short-acting intravenous drugs. The choice of antihypertensive drug will depend on the clinical situation and conditions of the patient, and should take into account the pharmacokinetic and pharmacodynamic parameters of the different agents available. INTRODUCTION Oral poliovirus vaccine (OPV) and diphtheria-tetanus-acellular pertussis vaccine (DTaP) are widely used in China while Haemophilus influenzae type b vaccines (Hib) and a DTaP, inactivated poliovirus (IPV) andHib polysaccharide conjugated to tetanus protein (PRP&nbsp;~&nbsp;T) combined vaccine (DTaP-IPV//PRP&nbsp;~&nbsp;T) have lower coverage. There are limited safety data on these vaccines in Chinese pediatric populations. METHODS To estimate incidence rates (IRs) of health outcomes of interest (HOIs) among children exposed to OPV, DTaP, Hib, and DTaP-IPV//PRP&nbsp;~&nbsp;T, we conducted a retrospective cohort study using a population-based electronic health record (EHR) database in Yinzhou district, Ningbo City. Children 0-2&nbsp;years of age receiving at least one dose of these vaccines between January 1, 2012 and March 31, 2017 were included in the study. Yinzhou EHR database consisted of immunization records and healthcare data of children from hospitals and community health centers in the district. Eight HOIs (i.e., anaphylaxis, febrile seizures, all seizures, asthma, apnea, Kawasaki disease [KD], urticaria/angioedema, Guillain-Barré syndrome [GBS]) were identified using ICD-10 codes. RESULTS A total of 220,422 eligible children was identified. No cases of apnea, KD, and GBS were observed within 7&nbsp;days post-vaccination. During 0-7&nbsp;days post-vaccination for OPV, DTaP, Hib, and DTaP-IPV//PRP&nbsp;~&nbsp;T, the IRs of anaphylaxis, febrile seizures, all seizures, urticaria/angioedema and asthma ranged from 0.0 to 50.0, 0.0 to 99.9, 29.1 to 249.8, 297.8 to 949.1, and 992.7 to 2298.2 per 100,000 person-years, respectively, and 0.0 to 0.9, 0.0 to 1.9, 0.6 to 4.6, 5.6 to 17.5, and 18.7 to 42.3 per 100,000 doses, respectively. CONCLUSION IRs of some HOIs in our study were comparable with those in the literature while IRs of other HOIs were not due to differences in study design, post-vaccination risk periods assessed, and vaccine types. Future studies should consider medical chart review for validating HOIs obtained in the EHR. Neisseria meningitidis is the causative agent of meningococcal meningitis and sepsis and remains a significant public health problem in many countries. Efforts to develop a comprehensive vaccine against serogroup B meningococci have focused on the use of surface-exposed outer membrane proteins. Here we report the use of virus-like particles derived from the core protein of Hepatitis B Virus, HBc, to incorporate antigen domains derived from Factor H binding protein (FHbp) and the adhesin NadA. The extracellular domain of NadA was inserted into the major immunodominant region of HBc, and the C-terminal domain of FHbp at the C-terminus (CFHbp), creating a single polypeptide chain 3.7-fold larger than native HBc. Remarkably, cryoelectron microscopy revealed that the construct formed assemblies that were able to incorporate both antigens with minimal structural changes to native HBc. Electron density was weak for NadA and absent for CFHbp, partly attributable to domain flexibility. Following immunization of mice, three HBc fusions (CFHbp or NadA alone, NadA&nbsp;+&nbsp;CFHbp) were able to induce production of IgG1, IgG2a and IgG2b antibodies reactive against their respective antigens at dilutions in excess of 118,000.